S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.04%) $0.791
USD/RUB
(0.86%) $85.73

Realtime updates for Candel Therapeutics, Inc. [CADL]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Jun 2024 @ 16:00

5.26% $ 6.20

Live Chart Being Loaded With Signals

Commentary (28 Jun 2024 @ 16:00):
Our systems believe the stock currently is undervalued by 0.51% compare to its pairs and should correct upwards.
Profile picture for Candel Therapeutics, Inc.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma...

Stats
Today's Volume 3.58M
Average Volume 5.90M
Market Cap 184.49M
EPS $-0.280 ( Q1 | 2024-05-14 )
Next earnings date ( $0 ) 2024-08-08
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -4.81
(Sector) 42.63
(Industry) 24.32
ATR14 $0.0170 (0.27%)
AADI -10.43%
ABCL 2.78%
ABCM 0.04%
ABEO 1.19%
ABIO 6.39%
ABOS 2.54%
ABSI 0.98%
ABUS -0.32%
ABVX 3.69%
ACAD -0.73%
ACER -17.95%
ACET -9.70%
ACGN 1.29%
ACHL 0.62%
ACHV 1.29%
ACIU 0.50%
ACLX 1.98%
ACRV 0.69%
ACST -2.67%
ACXP -2.60%
ADAG 6.66%
ADAP -0.60%
ADGI 0.87%
ADIL 1.77%
ADMA 2.10%
ADPT 4.62%
ADTX -2.84%
ADVM -1.72%
ADXN -3.06%
AEON -0.94%
AEZS -2.64%
AFMD 0.00%
AGEN 18.63%
AGIO -1.12%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA 3.11%
AKRO 0.26%
AKTX 0.75%
AKUS 0.00%
ALBO 0.00%
ALDX -2.65%
ALEC 0.00%
ALGS -7.51%
ALKS -0.78%
ALLK -5.66%
ALLO -4.51%
ALLR 3.85%
ALNA 3.16%
ALNY -1.62%
ALPN 0.02%
ALPX 0.00%
ALRN -4.48%
ALT 4.15%
ALVR -7.27%
ALXN 0.00%
ALXO 3.34%
ALZN -0.65%
AMRN -1.84%
AMTI -3.13%
ANAB 1.05%
ANEB 3.80%
ANGN 0.00%
ANIX -7.14%
ANL -6.05%
ANNX 1.66%
ANPC -3.15%
APGE -1.50%
APGN 8.48%
APGNW 30.65%
APLM 1.30%
APLS -7.61%
APLT 1.52%
APM -5.26%
APOP 0.38%
APRE -0.49%
APTO 1.20%
APTX 3.17%
APVO -40.57%
ARAV -13.39%
ARCT -0.41%
ARDS -17.87%
ARDX 14.00%
ARGX -3.35%
ARNA 0.00%
ARPO -0.90%
ARQT -1.27%
ARTL 3.08%
ARTLW 0.00%
ARVN 2.98%
ARWR 1.17%
ASLN 4.90%
ASMB -6.03%
ASND 0.72%
ATAI 0.76%
ATHA 0.38%
ATHE 0.56%
ATHX -33.50%
ATNF 9.27%
ATOS 4.39%
ATRA 2.91%
ATXI -2.23%
ATXS -1.30%
AUPH 1.60%
AURA 3.85%
AUTL 4.50%
AVBP 6.61%
AVEO 0.00%
AVIR -2.07%
AVRO -1.41%
AVTE -0.60%
AVTX -5.53%
AVXL -1.63%
AXLA 0.00%
AXSM 0.51%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 0.52%
BCAB -6.80%
BCDA -0.34%
BCDAW 0.00%
BCEL 0.00%
BCLI -6.08%
BCRX 1.15%
BCTX 9.62%
BCTXW 1.47%
BCYC -0.15%
BDRX 2.98%
BDTX -0.85%
BEAM -2.29%
BFRA -2.91%
BGNE -2.00%
BIOR 2.37%
BIVI -10.22%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -1.37%
BLTE -1.76%
BLU 0.03%
BLUE 3.74%
BMEA -0.66%
BMRN -1.40%
BNOX 3.51%
BNTC -0.71%
BNTX -0.02%
BOLD -14.76%
BOLT 0.32%
BPMC -0.68%
BPTH 2.56%
BPTS -13.47%
BRNS 1.45%
BRTX 10.93%
BTAI 0.79%
BTTX 30.91%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI -2.44%
CABA 1.91%
CADL 5.26%
CALA 0.00%
CALC 25.71%
CALT 0.72%
CAPR 2.80%
CARA -15.27%
CARM 18.75%
CASI 12.24%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS 3.79%
CCCC 0.00%
CCXI 0.00%
CDAK 0.00%
CDIO 0.37%
CDIOW 21.56%
CDMO 1.85%
CDMOP 0.04%
CDT 3.92%
CDTTW -12.92%
CDTX 6.70%
CDXC 3.02%
CDXS 2.99%
CELC 0.68%
CELU 11.79%
CELUW 0.00%
CERC -1.68%
CERE 0.96%
CERO -1.77%
CEROW 43.57%
CFRX -27.95%
CGEM 2.05%
CGEN -4.55%
CGON 4.36%
CGTX -0.60%
CHMA -6.00%
CHRS 1.76%
CINC 0.00%
CING -45.21%
CINGW 4.85%
CKPT 4.37%
CLBS -16.75%
CLDX -1.80%
CLGN -0.60%
CLLS 0.54%
CLNN -3.47%
CLNNW 3.32%
CLRB 7.30%
CLSD 1.56%
CLSN -0.68%
CLVS 0.00%
CMMB -4.26%
CMND 25.37%
CMPI 0.00%
CMPX -16.67%
CMRA 0.00%
CMRAW 33.33%
CMRX -1.47%
CNCE 0.00%
CNSP -4.82%
CNST 0.00%
CNTA 0.56%
CNTB 18.75%
CNTX -0.25%
COCP -8.63%
COEPW 0.00%
COGT -0.12%
CORT 1.34%
COYA -0.49%
CPRX 2.99%
CRBP 3.12%
CRBU -2.38%
CRDF -4.72%
CRGX 4.99%
CRIS -7.38%
CRNX 3.04%
CRSP -2.47%
CRTX 2.63%
CRVO -0.29%
CRVS -2.67%
CSBR 0.39%
CTCX 9.02%
CTIC 0.06%
CTMX -3.17%
CTNM -6.08%
CTXR -8.54%
CUE -11.43%
CVAC 1.19%
CVKD 1.82%
CWBR 0.00%
CYAD -12.96%
CYCC -4.71%
CYCCP -11.68%
CYCN 5.99%
CYT -2.27%
CYTK 0.74%
CYTO 0.00%
DARE -8.79%
DAWN -0.36%
DBTX -0.81%
DBVT -5.53%
DFFN 10.28%
DICE 0.06%
DMAC -3.28%
DNLI 1.09%
DNTH 3.85%
DOMH -1.58%
DRMA 4.37%
DRMAW 7.69%
DRNA 0.00%
DRTS 23.41%
DRTSW -8.84%
DRUG 2.32%
DSGN 0.00%
DTIL 3.29%
DYAI -6.33%
EARS -1.77%
EDIT -1.48%
EDSA -2.51%
EFTR -6.42%
EFTRW 0.00%
EIGR -9.21%
ELAB -1.48%
ELDN 1.54%
ELEV 7.57%
ELOX 12.20%
ELTX -40.35%
ELVN -0.34%
ELYM -5.58%
ENGN 5.13%
ENGNW -0.83%
ENLV -4.70%
ENOB 1.79%
ENSC -2.78%
ENTA 2.37%
ENTO 2.51%
ENTX -5.64%
ENVB 0.71%
EPIX 1.54%
EPRX 0.78%
EPZM 0.00%
EQ 3.77%
EQRX -2.09%
EQRXW 0.00%
ERAS 2.16%
ERNA 5.17%
ERYP 1.30%
ESLA 12.90%
ESLAW 0.00%
ETNB 6.23%
ETON -0.90%
ETTX 0.00%
EVAX 1.05%
EVGN -5.74%
EVLO 0.00%
EWTX 2.91%
EXAI -2.30%
EXEL -0.27%
EYEG -0.50%
EYEN -14.16%
EYPT -0.57%
FATE 0.46%
FBIO 1.79%
FBIOP 1.02%
FBLG 7.08%
FBRX -2.01%
FDMT 0.29%
FENC -0.65%
FGEN -13.37%
FHTX 0.17%
FIXX 0.77%
FMTX 0.00%
FNCH 13.22%
FOLD 0.10%
FREQ 4.76%
FRLN 0.15%
FRTX 5.56%
FSTX 0.00%
FTRE 2.01%
FULC -1.27%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT 2.73%
GANX 2.40%
GBIO -1.05%
GBT 0.01%
GDTC 5.05%
GERN -4.50%
GHRS -2.75%
GLMD 2.46%
GLPG -1.43%
GLSI 2.25%
GLTO -5.16%
GLUE 10.65%
GLYC -11.22%
GMAB -1.76%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -6.48%
GNLX -11.36%
GNPX -3.33%
GNTA -0.32%
GOSS -5.38%
GOVX -10.28%
GOVXW -20.59%
GPCR 0.33%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS -12.42%
GRTX 1.33%
GTHX 1.33%
GUTS -3.61%
GXGXW 41.67%
GYRE 20.63%
HALO 1.41%
HARP 0.09%
HCWB 1.06%
HEPA -5.55%
HGEN -84.62%
HILS 5.66%
HLVX 8.15%
HOOK -8.97%
HOTH -0.79%
HOWL -2.79%
HRMY -4.16%
HRTX 2.64%
HSTO 0.00%
HUMA 2.13%
HUMAW -1.42%
IBRX -3.36%
ICCC 11.24%
ICPT 0.21%
ICU 10.16%
ICUCW 12.50%
ICVX -0.91%
IDRA -23.04%
IDYA 2.15%
IFRX 4.19%
IGMS 3.93%
IKNA -5.71%
IKT -12.32%
IMAB -1.18%
IMCR 0.33%
IMGN 0.02%
IMGO 0.00%
IMMP 7.49%
IMMX -7.04%
IMNM 1.09%
IMNN 0.87%
IMPL -27.27%
IMRA 15.96%
IMRN -3.97%
IMRX -10.49%
IMTX -1.44%
IMTXW 2.21%
IMUX 8.82%
IMV 0.00%
IMVT 1.54%
INAB -5.87%
INBX 0.78%
INCY -1.19%
INDP -7.02%
INFI -52.38%
INKT 2.06%
INM 0.19%
INMB 1.50%
INO 4.12%
INSM 0.07%
INTS 0.20%
INVA 1.23%
INZY -1.33%
IOBT -0.85%
IONS 0.91%
IOVA 0.12%
IPA 1.23%
IPHA -1.52%
IPSC 0.79%
IRON 1.62%
ISEE 0.38%
ITOS -4.26%
ITRM -4.58%
IVA -0.33%
IVVD -8.33%
JAGX -1.11%
JANX 3.84%
JAZZ -0.35%
JNCE 0.00%
JSPR 3.13%
JSPRW 5.15%
JUNS 0.00%
JUNSW 0.00%
KA -5.43%
KALV -2.24%
KDNY 0.22%
KMPH -0.34%
KNSA 0.43%
KNTE -0.38%
KOD -3.29%
KPRX 1.20%
KPTI -10.84%
KRBP 6.83%
KRON 3.33%
KROS 1.40%
KRRO 1.20%
KRTX 0.03%
KRYS 0.42%
KTRA -3.60%
KTTA 1.62%
KTTAW 0.92%
KURA 0.44%
KYMR -1.22%
KYTX 1.90%
KZIA 2.65%
KZR -5.41%
LABP 0.57%
LBPH 20.19%
LBPS 0.00%
LBPSW 14.81%
LEGN -0.83%
LENZ -2.92%
LEXX 5.70%
LEXXW -5.15%
LGND 2.34%
LGNDV 0.00%
LGVN -4.17%
LIAN -8.28%
LIFE 2.70%
LIPO -3.43%
LIXT -2.47%
LIXTW -3.71%
LJPC -0.32%
LMNL 0.12%
LOGC -2.06%
LPCN 6.32%
LPTX 10.73%
LQDA -3.07%
LRMR -1.36%
LSTA -0.57%
LTRN 2.86%
LUMO 2.20%
LVTX -3.74%
LXEO 7.94%
LXRX -3.45%
LYEL 5.07%
LYRA 5.93%
MACK 0.10%
MBIO 1.59%
MBRX -3.83%
MCRB -7.80%
MDGL -1.93%
MDNA -13.16%
MDWD 4.30%
MDXG 2.51%
MEIP -1.36%
MESO -0.58%
MGNX 3.16%
MGTA -7.74%
MGTX -0.47%
MGX 8.22%
MIRM 3.26%
MIRO 0.59%
MIST 2.33%
MITO 0.00%
MLEC 1.85%
MLECW -28.57%
MLND -5.36%
MLTX 5.47%
MLYS 1.74%
MNKD -1.32%
MNMD -0.55%
MNOV 0.00%
MNPR -1.67%
MOLN 4.33%
MOR 0.17%
MORF 0.18%
MREO 3.45%
MRKR 12.42%
MRNA -2.01%
MRNS -4.88%
MRSN 0.75%
MRTX -0.17%
MRUS -1.71%
MRVI 1.13%
MTCR -1.29%
MTEM 3.60%
MTP -18.50%
MURA 2.28%
MYMD -1.08%
NAMS -1.69%
NAMSW -3.11%
NAUT 2.63%
NBRV 0.71%
NBSE -1.56%
NBTX -10.71%
NCNA -4.49%
NERV 4.59%
NEXI 0.00%
NGM -1.28%
NGNE 4.51%
NKGN 2.42%
NKGNW -12.00%
NKTR 8.77%
NKTX 0.85%
NLSP -9.63%
NLSPW 7.48%
NMRA 6.85%
NMTR -42.97%
NOVN -24.84%
NRBO 0.83%
NRIX 0.63%
NRSN 9.80%
NRSNW 21.18%
NRXP -6.87%
NRXPW -16.53%
NRXS 4.51%
NTBL -6.32%
NTEC -12.45%
NTHI 0.00%
NTLA -3.49%
NTRBW 74.65%
NUVL -1.44%
NVAX -1.33%
NVCT 0.96%
NVIV -34.28%
NXTC -3.05%
NYMX -0.05%
OABI -0.53%
OABIW 6.37%
OBIO 2.77%
OBSV 0.00%
OCEA -11.59%
OCGN 8.39%
OCS 1.44%
OCUL 1.18%
OCUP 0.66%
ODT -4.27%
OKYO 0.85%
OLMA -3.48%
OMER 2.78%
OMGA -7.59%
ONCO -18.40%
ONCR -3.08%
ONCS 31.87%
ONCT -1.17%
ONCY -1.98%
ONTX -0.47%
ONVO -0.41%
OPNT 0.00%
OPT 3.21%
ORGS -5.36%
ORIC 2.32%
ORMP -4.10%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.73%
OVID 5.89%
OYST 0.00%
PALI -1.53%
PASG -14.04%
PBLA 11.11%
PBM -8.81%
PBYI 0.93%
PCSA 8.21%
PCVX -4.14%
PDSB -2.66%
PEPG -3.04%
PGEN 4.64%
PHAR 3.47%
PHAS 0.00%
PHAT -0.96%
PHIO 1.75%
PHIOW 36.47%
PHVS 4.39%
PHXM -5.20%
PIRS 5.83%
PKBO 0.00%
PKBOW 999 900.00%
PLRX 0.84%
PLUR 7.04%
PMN -1.96%
PMVP -2.41%
PNT 0.16%
PPBT -6.42%
PRAX 4.02%
PRDS 0.93%
PRLD 3.25%
PROG -3.47%
PROK 1.65%
PRQR 0.61%
PRTA 0.54%
PRTC 4.56%
PRTG -6.11%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -1.34%
PSTX 7.35%
PTCT -11.77%
PTE -0.82%
PTGX 8.69%
PTIXW -47.77%
PULM 0.52%
PXMD -9.45%
PYPD 3.12%
PYXS 3.12%
QLGN -3.31%
QNCX 4.87%
QNRX -2.85%
QSI 11.70%
QSIAW 4.08%
QTTB 17.70%
QURE -1.32%
RAIN -1.63%
RANI -3.55%
RAPT 5.54%
RARE -0.77%
RCKT 0.47%
REGN 0.02%
RENB 16.67%
REPL 5.63%
RETA 0.02%
REUN -0.89%
REVB 2.69%
REVBU 3.46%
REVBW 19.05%
RGLS -11.85%
RGNX 0.60%
RIGL -13.75%
RLAY 3.49%
RLMD 0.33%
RLYB -9.46%
RNA 0.76%
RNAC -5.29%
RNAZ -0.50%
RNXT -2.59%
ROIV 0.00%
ROIVW 4.56%
RPHM -6.21%
RPRX -1.12%
RPTX -2.37%
RUBY 2.70%
RVLP -32.05%
RVMD 0.73%
RVMDW 45.86%
RVNC -0.39%
RVPH 0.00%
RVPHW 1.89%
RXDX 0.09%
RXRX -0.99%
RYTM 2.32%
RYZB 0.02%
RZLT 7.23%
SABS 6.16%
SABSW 35.43%
SAGE 1.59%
SANA 1.11%
SAVA -34.83%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI -2.80%
SCPH -0.46%
SCPS 0.00%
SEEL -2.10%
SEER -4.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO -10.11%
SGMT -16.79%
SGTX -2.56%
SIOX 22.63%
SLDB -1.22%
SLGL 3.37%
SLN 0.00%
SLNO -2.28%
SLRX -2.86%
SLS 4.39%
SMMT -0.89%
SNDX 1.03%
SNGX -7.19%
SNPX 0.99%
SONN -1.41%
SPPI -0.49%
SPRB -2.72%
SPRC -5.99%
SPRO -2.99%
SRNE 5.26%
SRPT 0.03%
SRRA 0.00%
SRRK -0.36%
SRZN 10.16%
STAB 0.00%
STOK 1.50%
STRO 0.34%
STSA 0.00%
STTK 2.93%
SURF -0.93%
SVRA 5.77%
SWTX 0.37%
SYBX -1.96%
SYRS -9.95%
TALS -0.73%
TARA -4.15%
TARS 7.99%
TBPH 1.80%
TCBP -1.31%
TCDA 0.00%
TCON -1.38%
TCRR 0.00%
TCRT -2.92%
TCRX -6.25%
TECH -0.24%
TENX 1.17%
TERN -4.22%
TFFP 3.11%
TGTX -0.89%
THRX 0.12%
TIL -1.06%
TLC 0.00%
TLSA 4.43%
TNGX 0.47%
TNXP 1.07%
TNYA 5.44%
TPST 0.92%
TRDA 0.56%
TRVI 1.36%
TRVN 1.40%
TSHA 3.46%
TSVT 2.39%
TTNP 0.91%
TVTX -0.72%
TYRA 3.50%
UBX -2.17%
UNCY 23.70%
URGN -1.12%
UTHR 0.51%
VACC 11.36%
VALN -5.14%
VAXX -0.24%
VBIV 1.54%
VBLT -8.77%
VCEL -2.20%
VCNX 2.69%
VCYT -1.46%
VERA 4.39%
VERU 5.16%
VERV 2.52%
VIGL -10.71%
VINC 9.46%
VIR 0.34%
VIRI -8.20%
VIRX -5.93%
VKTX 4.41%
VLON -13.04%
VNDA -2.75%
VOR -12.28%
VRCA 0.97%
VRDN 1.80%
VRNA -6.35%
VRPX -0.52%
VRTX -0.80%
VSTM 2.76%
VTGN 0.00%
VTVT -0.34%
VTYX -3.35%
VXRT 0.20%
VYGR 0.64%
VYNE 0.00%
VYNT 7.78%
WINT -3.60%
WVE 0.00%
XBIO 1.50%
XBIT 11.50%
XCUR 5.89%
XENE 4.22%
XERS -0.44%
XFOR -13.45%
XLO 0.80%
XLRN 0.00%
XNCR -1.41%
XOMA 3.45%
XOMAO 0.24%
XOMAP 0.08%
XRTX 0.00%
YMAB -2.03%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -1.08%
ZNTL -2.62%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2024-06-26 Papa Joseph C Buy 14 240 Stock Option (Right to Buy)
2024-06-26 Nguyen Diem Buy 14 240 Stock Option (Right to Buy)
2024-06-26 Nabel Gary J. Buy 14 240 Stock Option (Right to Buy)
2024-06-26 Martell Christopher Buy 14 240 Stock Option (Right to Buy)
2024-06-26 Manning Paul B Buy 14 240 Stock Option (Right to Buy)
INSIDER POWER
78.07
Last 92 transactions
Buy: 6 895 758 | Sell: 2 894 136
Correlation (AI algo v.1.1b): Undervalued: 0.51% $6.26 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: 0.61 (weak)
Short: 0.19 (neutral)
Signal:(73.67) Neutral

Candel Therapeutics, Inc. Correlation

10 Most Positive Correlations
IZEA0.96
SMTC0.959
MESO0.951
QRHC0.948
JAGX0.942
LE0.938
USAP0.937
CHCI0.93
LSAK0.928
PAYS0.928
10 Most Negative Correlations
OZEM-1
LINK-0.941
APDN-0.927
HUGE-0.915
ASNS-0.914
VEEE-0.913
MBIO-0.913
ALLR-0.91
ARAY-0.909
WVVI-0.908

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Candel Therapeutics, Inc. Correlation - Currency/Commodity

The country flag -0.06
( neutral )
The country flag -0.25
( neutral )
The country flag 0.00
( neutral )
The country flag -0.46
( neutral )
The country flag 0.42
( neutral )
The country flag 0.10
( neutral )

Candel Therapeutics, Inc. Financials

Annual 2023
Revenue: $0
Gross Profit: $-1.20M (0.00 %)
EPS: $-1.310
FY 2023
Revenue: $0
Gross Profit: $-1.20M (0.00 %)
EPS: $-1.310
FY 2022
Revenue: $125 000
Gross Profit: $-862 000 (-689.60 %)
EPS: $-0.0994
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.934

Financial Reports:

No articles found.

Candel Therapeutics, Inc. Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Candel Therapeutics, Inc.

Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of high-grade glioma. It also develops CAN-3110, which is in Phase I clinical trials for the treatment of recurrent glioblastoma. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. The company was incorporated in 2003 and is based in Needham, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.7319800853729 seconds
Number of API calls: 3
Number of DB calls: 9